Diabetes Clinical Trials in Washington

Showing 341-360 of 382 trials

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance

NCT00865345

The purpose of this study is to assess the performance of the subcutaneous glucose sensor over an extended sensor life. The sensor is currently approved for 3 days of use and this study will examine sensor safety and accuracy when used for six days. This study will also test sensor safety and accuracy when inserted in an alternate body location (buttock area in addition to abdomen area). The study hypothesis is that the sensor performance will not greatly diminish when used for six days, or in an alternate insertion area.

Diabetes

Medtronic MiniMed, Inc.63 participantsStarted Mar 2009

Escondido, California, United States • Santa Barbara, California, United States • Renton, Washington, United States

COMPLETEDPhase 234 miles

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00476931

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics91 participantsStarted May 2007

La Jolla, California, United States • Lakewood, California, United States • Lomita, California, United States +17 more locations

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Diabetes Trials in Other Cities

Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Dose Ranging Study With LT, Monotherapy, PPAR

Follow-Up Study for Exubera

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

PPAR-COMBO With Sulfonylurea

GALLANT 6 Tesaglitazar vs. Pioglitazone

Testing the Developmental Origins Hypothesis

A Study for Patients With Type 2 Diabetes Mellitus

DPBRN Blood Sugar Testing in Dental Patients

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Other Conditions in Washington